Detecting stomach disease, screening early cancer, dynamically monitor the status of stomach disease.
The development of gastric cancer is: chronic gastritis → atrophic gastritis → intestinal metaplasia → dysplasia → gastric cancer, if it can be treated before atrophic gastritis, it can reduce the incidence of gastric cancer. Therefore, it is particularly important to accurately determine the degree of gastric mucosal atrophy and control gastric cancer.
The glands of the gastric mucosa can secrete Pepsinogen, and Pepsinogen can enter the blood in a small amount. Therefore, by examining the content of Pepsinogen from the blood, the degree of atrophy of the gastric mucosa can be inferred, and conducive to the prevention and treatment of gastric cancer.
The kit is produced by Wuxi Jiangyuan Industrial Technology and Trade Corporation, and uses Time-resolved fluorescence immunoassay to detect Pepsinogen in the blood.